NO20064160L - New azaibicyclic compounds, processes for their preparation and pharmaceutical compositions containing them - Google Patents

New azaibicyclic compounds, processes for their preparation and pharmaceutical compositions containing them

Info

Publication number
NO20064160L
NO20064160L NO20064160A NO20064160A NO20064160L NO 20064160 L NO20064160 L NO 20064160L NO 20064160 A NO20064160 A NO 20064160A NO 20064160 A NO20064160 A NO 20064160A NO 20064160 L NO20064160 L NO 20064160L
Authority
NO
Norway
Prior art keywords
compounds
azaibicyclic
processes
preparation
new
Prior art date
Application number
NO20064160A
Other languages
Norwegian (no)
Other versions
NO337013B1 (en
Inventor
Patrick Casara
Brian Lockhart
Pierre Lestage
Alain Dhainaut
Anne-Marie Chollet
Lionel Bert
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20064160L publication Critical patent/NO20064160L/en
Publication of NO337013B1 publication Critical patent/NO337013B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Oppfinnelsen vedrører forbindelser med formel (I): enantiomerene og diastereoisomerene derav, samt deres addisjonssalter med én eller flere syrer eller én eller flere farmasøytisk akseptable baser. De oppfinneriske forbindelser er av spesiell interesse for sin interaksjon med sentrale histaminergiske systemer.The invention relates to compounds of formula (I): the enantiomers and diastereoisomers thereof, as well as their addition salts with one or more acids or one or more pharmaceutically acceptable bases. The inventive compounds are of particular interest for their interaction with central histaminergic systems.

NO20064160A 2004-02-20 2006-09-14 New azaibicyclic compounds, processes for their preparation and pharmaceutical compositions containing them NO337013B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0401690A FR2866647B1 (en) 2004-02-20 2004-02-20 NOVEL AZABICYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PCT/FR2005/000382 WO2005089747A1 (en) 2004-02-20 2005-02-18 Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same

Publications (2)

Publication Number Publication Date
NO20064160L true NO20064160L (en) 2006-09-14
NO337013B1 NO337013B1 (en) 2015-12-21

Family

ID=34833930

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064160A NO337013B1 (en) 2004-02-20 2006-09-14 New azaibicyclic compounds, processes for their preparation and pharmaceutical compositions containing them

Country Status (30)

Country Link
US (1) US7576120B2 (en)
EP (1) EP1720544B1 (en)
JP (1) JP4519861B2 (en)
KR (1) KR100885104B1 (en)
CN (2) CN101230033B (en)
AR (3) AR047685A1 (en)
AT (1) ATE389398T1 (en)
AU (1) AU2005224129B2 (en)
BR (1) BRPI0507830A (en)
CA (1) CA2555216C (en)
CY (1) CY1108529T1 (en)
DE (1) DE602005005456T2 (en)
DK (1) DK1720544T3 (en)
EA (1) EA010300B1 (en)
ES (1) ES2303233T3 (en)
FR (1) FR2866647B1 (en)
GE (1) GEP20094578B (en)
HK (1) HK1123789A1 (en)
HR (1) HRP20080184T5 (en)
MA (1) MA28342A1 (en)
ME (1) ME01400B (en)
MY (1) MY137282A (en)
NO (1) NO337013B1 (en)
NZ (1) NZ548898A (en)
PL (1) PL1720544T3 (en)
PT (1) PT1720544E (en)
RS (1) RS50577B (en)
SI (1) SI1720544T1 (en)
WO (1) WO2005089747A1 (en)
ZA (1) ZA200606558B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1717235A3 (en) * 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
EP1717234A1 (en) * 2005-04-29 2006-11-02 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
US20090023731A1 (en) * 2007-03-22 2009-01-22 Arete Therapeutics, Inc. Soluble epoxide hydrolase inhibitors
FR2932479A1 (en) * 2008-06-13 2009-12-18 Servier Lab NOVEL AZABICYCLIC DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2937251B1 (en) * 2008-10-16 2011-03-18 Servier Lab USE OF 4- {3- HEXAHYDROCYCLOPENTA} C! PYRROL-2 (1H) -YL! PROPOXY} BENZAMIDE FOR THE PRODUCTION OF MEDICAMENTS FOR THE TREATMENT OF SLEEP DISORDERS
FR2953515B1 (en) * 2009-12-09 2011-12-23 Servier Lab NOVEL HEXAHYDROCYCLOPENTA [B] PYRROLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2953521B1 (en) * 2009-12-09 2011-11-18 Servier Lab NOVEL AZABICYCLO [3.1.0] HEX-2-YL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2953513B1 (en) 2009-12-09 2011-12-23 Servier Lab NOVEL AZABICYCLO [3.2.0] HEPT-6-YL DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2953514B1 (en) * 2009-12-09 2011-12-23 Servier Lab NOVEL AZABICYCLO [3.2.0] HEPT-3-YL DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2974729B1 (en) * 2011-05-02 2013-04-19 Servier Lab NOVEL ASSOCIATION BETWEEN 4- {3- [CIS-HEXAHYDROCYCLOPENTA [C] PYRROL-2 (1H) -YL] PROPOXY} BENZAMIDE AND AN ACETYLCHOLINESTERASE INHIBITOR AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2976286B1 (en) 2011-06-08 2013-05-24 Servier Lab 4- {3- [TRANS-HEXAHYDROCYCLOPENTA [C] PYRROL-2 (1H) -YL] PROPOXY} BENZAMIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2976285B1 (en) 2011-06-08 2013-05-24 Servier Lab PROCESS FOR THE SYNTHESIS AND CRYSTALLINE FORM OF 4- {3- [CIS-HEXAHYDROCYPENTA [C] PYRROL-2 (1H) -YL] PROPOXY} BENZAMIDE HYDROCHLORIDE AS WELL AS THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
AU2012349290B2 (en) 2011-12-08 2017-03-23 Taisho Pharmaceutical Co., Ltd. Phenylpyrrole derivative
FR2983732B1 (en) * 2011-12-09 2013-11-22 Servier Lab NOVEL ASSOCIATION BETWEEN 4- {3- [CIS-HEXAHYDROCYCLOPENTA [C] PYRROL-2 (1H) -YL] PROPOXY} PHARMACEUTICALS CONTAINING THE SAME
US20150045553A1 (en) * 2011-12-27 2015-02-12 Taisho Pharmaceutical Co., Ltd Phenyltriazole derivative
CN103183632A (en) * 2011-12-29 2013-07-03 山东方明药业集团股份有限公司 Purification method of 3-azabicyclo-octane hydrochloride
FR2999179A1 (en) * 2012-12-07 2014-06-13 Servier Lab PROCESS FOR THE SYNTHESIS OF A SALT FOR ADDITION TO A PHARMACEUTICALLY ACCEPTABLE ACID OF 4- {3- [CIS-HEXAHYDROCYCLOPENTA [C] PYRROL-2 (1H) -YL] PROPOXY} BENZAMIDE, AND ASSOCIATED CRYSTALLINE FORMS
FR3003466B1 (en) 2013-03-22 2015-08-07 Servier Lab USE OF 4- {3- [CIS-HEXAHYDROCYCLOPENTA [C] PYRROL-2 (1H) -YL] PROPOXY} BENZAMIDE FOR THE TREATMENT OF NEUROPATHIC PAIN
EP3594205A1 (en) 2018-07-09 2020-01-15 Abivax Phenyl-n-aryl derivatives for treating a rna virus infection
EP3594206A1 (en) * 2018-07-09 2020-01-15 Abivax Phenyl-n-quinoline derivatives for treating a rna virus infection
CN111377911B (en) * 2018-12-27 2022-05-24 江苏恩华药业股份有限公司 Morpholine benzamide compound and application thereof
CN111377846B (en) * 2018-12-27 2022-05-24 江苏恩华药业股份有限公司 Piperazine benzamide derivative and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2962496A (en) * 1957-01-28 1960-11-29 Geschickter Fund Med Res Nu-substituted-3-azabicyclooctanes [3: 3: 0] and salts thereof
DE4341403A1 (en) * 1993-12-04 1995-06-08 Basf Ag N-substituted 3-azabicycloalkane derivatives, their preparation and use
DE60112942T2 (en) * 2000-06-30 2006-06-22 Elan Pharmaceuticals, Inc., South San Francisco COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
DE60130460T2 (en) * 2000-07-13 2008-06-05 Abbott Laboratories, Abbott Park 1,3-DISUBSTITUTED AND 1,3,3-TRISUBSTITUTED PYRROLIDINES AS LIGANDS OF THE HISTAMIN-3 RECEPTOR AND THEIR THERAPEUTIC APPLICATIONS
FR2827288B1 (en) * 2001-07-12 2003-10-31 Servier Lab NOVEL OCTAHYDRO-2H-PYRIDO [1,2-A] PYRAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
AU2005224129A1 (en) 2005-09-29
FR2866647B1 (en) 2006-10-27
GEP20094578B (en) 2009-01-12
KR20060114382A (en) 2006-11-06
WO2005089747A1 (en) 2005-09-29
JP4519861B2 (en) 2010-08-04
CY1108529T1 (en) 2014-04-09
FR2866647A1 (en) 2005-08-26
ES2303233T3 (en) 2008-08-01
CA2555216C (en) 2011-10-11
PL1720544T3 (en) 2008-05-30
AR094601A2 (en) 2015-08-12
CN101230033A (en) 2008-07-30
EP1720544B1 (en) 2008-03-19
HRP20080184T5 (en) 2008-10-31
MA28342A1 (en) 2006-12-01
ME01400B (en) 2013-12-20
CA2555216A1 (en) 2005-09-29
ATE389398T1 (en) 2008-04-15
DE602005005456T2 (en) 2009-04-09
CN100577160C (en) 2010-01-06
US20070197625A1 (en) 2007-08-23
PT1720544E (en) 2008-05-08
HRP20080184T3 (en) 2008-05-31
CN1921848A (en) 2007-02-28
ZA200606558B (en) 2008-01-08
MY137282A (en) 2009-01-30
DE602005005456D1 (en) 2008-04-30
AR089451A2 (en) 2014-08-27
DK1720544T3 (en) 2008-07-21
EP1720544A1 (en) 2006-11-15
SI1720544T1 (en) 2008-06-30
NO337013B1 (en) 2015-12-21
NZ548898A (en) 2010-06-25
AU2005224129B2 (en) 2010-08-12
EA010300B1 (en) 2008-08-29
KR100885104B1 (en) 2009-02-20
CN101230033B (en) 2011-03-09
HK1123789A1 (en) 2009-06-26
EA200601512A1 (en) 2007-02-27
BRPI0507830A (en) 2007-07-10
AR047685A1 (en) 2006-02-01
RS50577B (en) 2010-05-07
US7576120B2 (en) 2009-08-18
JP2007523135A (en) 2007-08-16

Similar Documents

Publication Publication Date Title
NO20064160L (en) New azaibicyclic compounds, processes for their preparation and pharmaceutical compositions containing them
NO20055219L (en) New connections
NO20055688L (en) Organic compounds
NO20071504L (en) Pyrimidinderivanter.
NO20090835L (en) New HIV reverse transcriptase inhibitors
NO20082124L (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
NO20056010L (en) Biaryloksymetylaren acids
NO20085176L (en) Phenyl substituted heteroaryl derivatives and use as anti-tumor agents
NO20072978L (en) New betuene derivatives, their preparation and their use
NO20066055L (en) pyridine derivatives
NO20070339L (en) 1-aza-bicyclo [3 3.1] nonanes
NO20085212L (en) New pyridine analogs
SE0301009D0 (en) Novel compounds
NO20092723L (en) Indazolyl esters and amide derivatives for the treatment of glucocorticoid receptor-mediated diseases
NO20061406L (en) Organic compounds
NO20050088L (en) Cationically substituted diphenylazofidinones, processes for their preparation, medicaments containing said compounds, and use thereof
WO2006100081A3 (en) Substituted oxindole derivatives, medicaments containing the latter and use thereof
NO20076006L (en) acetylene Derivatives
NO20074258L (en) Pyridine-2-carboxamide derivatives as MGLUR5 antagonists
NO20062824L (en) 1,3-Diphenylprop-2-en-1-one derived compounds, processes for their preparation, and use of the same
NO20085214L (en) New pyridine analogs
ME00680B (en) Novel diomestine derivatives, method for preparing same and pharmaceutical compositions containing same
TNSN04250A1 (en) Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof.
NO20076682L (en) New pyridine analogs
NO20085213L (en) New pyridine analogs

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees